What is the purpose of the ex officio licence, if it is not used during a pandemic?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:76 |
|---|---|
| Enthalten in: |
Therapie - 76(2021), 4 vom: 15. Juli, Seite 377-379 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
À quoi sert la licence d’office, si elle n’est pas utilisée lors d’une pandémie ? |
|---|
| Beteiligte Personen: |
Rochoy, Michaël [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 31.08.2021 Date Revised 31.08.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.therap.2021.05.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM325739587 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM325739587 | ||
| 003 | DE-627 | ||
| 005 | 20231225193058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.therap.2021.05.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1085.xml |
| 035 | |a (DE-627)NLM325739587 | ||
| 035 | |a (NLM)34024641 | ||
| 035 | |a (PII)S0040-5957(21)00128-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Rochoy, Michaël |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a What is the purpose of the ex officio licence, if it is not used during a pandemic? |
| 246 | 3 | 3 | |a À quoi sert la licence d’office, si elle n’est pas utilisée lors d’une pandémie ? |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.08.2021 | ||
| 500 | |a Date Revised 31.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Ex officio licence | |
| 650 | 4 | |a Licence d’office | |
| 650 | 4 | |a Vaccines | |
| 650 | 4 | |a Vaccins | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Billy, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a Calafiore, Matthieu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Therapie |d 1947 |g 76(2021), 4 vom: 15. Juli, Seite 377-379 |w (DE-627)NLM000023655 |x 1958-5578 |7 nnns |
| 773 | 1 | 8 | |g volume:76 |g year:2021 |g number:4 |g day:15 |g month:07 |g pages:377-379 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.therap.2021.05.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 76 |j 2021 |e 4 |b 15 |c 07 |h 377-379 | ||